Article

Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose…

International Journal of Endocrinology · 2017 · Bing-li Liu, author Guo-ping Yin, author Feng-fei Li, author Yun Hu, author Jin-dan Wu, author Mao-yuan Chen, author Lei Ye, author Xiao-fei Su, author Jian-hua Ma, author Marco Bugliani, Academic Editor

Key facts

Title Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose Monitoring System in Patients with Newly Diagnosed Type 2 Diabetes
First author Bing-li Liu, author Guo-ping Yin, author Feng-fei Li, author Yun Hu, author Jin-dan Wu, author Mao-yuan Chen, author Lei Ye, author Xiao-fei Su, author Jian-hua Ma, author Marco Bugliani, Academic Editor
Journal International Journal of Endocrinology
Published Jul 14, 2017
DOI 10.1155/2018/2087960
Devices mentioned K001828, K021974, K030531, K031390, K032005, K151236, K160860, K864138, K874564, K880623, K901588, K913614 and 23 more
Product codes mentioned CGX, FPA, FRN, KZH, LCP, LGZ, LZG, MDS, MRZ, PJT, OZP, OYC and 3 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature